Table 4.
CLINICAL MANIFESTATION |
NAAT RESULT |
ANTIGEN TEST RESULT |
SEROLOGIC TEST RESULT |
RISK OF EXPERIENCING INFECTION TRANSMISSION |
|
---|---|---|---|---|---|
Immunoglobulin M | Immunoglobulin G | ||||
Early Stage of Infection | + | + | + | − | High |
Active Phase of Infection | + | + | + | + | High |
Late Stage of Infection, Possible Recurrent Infection | + | + | − | + | High |
Window Period | + | + | − | − | High |
Early Stage of Infection, False-Negative NAAT Result | − | + | + | − | High |
Late Stage of Infection, False-Negative NAAT Result | − | + | − | + | High |
Window Period, False-Negative NAAT Result | − | + | − | − | High |
Asymptomatic Infection, False-Positive NAAT Result, False-Positive SerologicTest Result | + | − | + | + | Low |
Window Period with Asymptomatic Infection, False-Positive NAAT Test Result | + | − | − | − | Low |
Past Infection | − | − | − | + | Low |
Convalescence | − | − | + | + | Low |
NAAT: Nucleic acid amplification test.